Search This Blog

Wednesday, March 13, 2019

Apyx Medical sees FY19 revenue $25M-$29M, consensus $25.88M

Sees FY19 Adjusted EBITDA loss in the range of $20.4 million to $19.4 million, compared to adjusted EBITDA loss from continuing operations of $11.7 million in FY18.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)